Annual Total Long Term Liabilities
$31.41 B
-$1.72 B-5.19%
31 December 2023
Summary:
AstraZeneca annual total long term liabilities is currently $31.41 billion, with the most recent change of -$1.72 billion (-5.19%) on 31 December 2023. During the last 3 years, it has risen by +$627.00 million (+2.04%). AZN annual total long term liabilities is now -27.76% below its all-time high of $43.48 billion, reached on 31 December 2021.AZN Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$38.19 B
+$2.02 B+5.57%
30 September 2024
Summary:
AstraZeneca quarterly total long term liabilities is currently $38.19 billion, with the most recent change of +$2.02 billion (+5.57%) on 30 September 2024. Over the past year, it has increased by +$7.91 billion (+26.14%). AZN quarterly long term liabilities is now -12.53% below its all-time high of $43.66 billion, reached on 30 September 2021.AZN Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.2% | +26.1% |
| 3 y3 years | +2.0% | -12.5% |
| 5 y5 years | +3.6% | +25.4% |
AZN Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -27.8% | +2.0% | -12.5% | +26.1% |
| 5 y | 5 years | -27.8% | +9.6% | -12.5% | +36.6% |
| alltime | all time | -27.8% | +1889.7% | -12.5% | +2323.3% |
AstraZeneca Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $38.19 B(+5.6%) |
| June 2024 | - | $36.18 B(+0.8%) |
| Mar 2024 | - | $35.89 B(+14.3%) |
| Dec 2023 | $31.41 B(-5.2%) | $31.41 B(+3.7%) |
| Sept 2023 | - | $30.28 B(-7.6%) |
| June 2023 | - | $32.75 B(-9.1%) |
| Mar 2023 | - | $36.02 B(+8.7%) |
| Dec 2022 | $33.13 B(-23.8%) | $33.13 B(-3.1%) |
| Sept 2022 | - | $34.18 B(-11.9%) |
| June 2022 | - | $38.81 B(-5.7%) |
| Mar 2022 | - | $41.17 B(-5.3%) |
| Dec 2021 | $43.48 B(+41.2%) | $43.48 B(-0.4%) |
| Sept 2021 | - | $43.66 B(+22.2%) |
| June 2021 | - | $35.73 B(+23.3%) |
| Mar 2021 | - | $28.97 B(-5.9%) |
| Dec 2020 | $30.78 B(+7.4%) | $30.78 B(-2.4%) |
| Sept 2020 | - | $31.55 B(+12.3%) |
| June 2020 | - | $28.09 B(+0.5%) |
| Mar 2020 | - | $27.95 B(-2.5%) |
| Dec 2019 | $28.66 B(-5.4%) | $28.66 B(-5.9%) |
| Sept 2019 | - | $30.46 B(-1.0%) |
| June 2019 | - | $30.78 B(+0.0%) |
| Mar 2019 | - | $30.77 B(+1.5%) |
| Dec 2018 | $30.32 B(-0.0%) | $30.32 B(-7.2%) |
| Sept 2018 | - | $32.66 B(+9.3%) |
| June 2018 | - | $29.87 B(-2.2%) |
| Mar 2018 | - | $30.54 B(+0.7%) |
| Dec 2017 | $30.33 B(-0.9%) | $30.33 B(-12.5%) |
| Sept 2017 | - | $34.68 B(+1.8%) |
| June 2017 | - | $34.05 B(+10.7%) |
| Mar 2017 | - | $30.75 B(+0.5%) |
| Dec 2016 | $30.60 B(+14.7%) | $30.60 B(-7.1%) |
| Sept 2016 | - | $32.93 B(-5.1%) |
| June 2016 | - | $34.69 B(+9.3%) |
| Mar 2016 | - | $31.75 B(+19.0%) |
| Dec 2015 | $26.68 B(+23.4%) | $26.68 B(+28.8%) |
| Sept 2015 | - | $20.71 B(-0.0%) |
| June 2015 | - | $20.72 B(-1.3%) |
| Mar 2015 | - | $20.99 B(-2.9%) |
| Dec 2014 | $21.62 B(+30.3%) | $21.62 B(+8.8%) |
| Sept 2014 | - | $19.87 B(-1.4%) |
| June 2014 | - | $20.16 B(-1.2%) |
| Mar 2014 | - | $20.40 B(+22.9%) |
| Dec 2013 | $16.59 B(+5.8%) | $16.59 B(+3.7%) |
| Sept 2013 | - | $16.00 B(+4.0%) |
| June 2013 | - | $15.38 B(-3.8%) |
| Mar 2013 | - | $15.98 B(+1.9%) |
| Dec 2012 | $15.69 B(+15.2%) | $15.69 B(-2.3%) |
| Sept 2012 | - | $16.06 B(+11.9%) |
| June 2012 | - | $14.35 B(+8.4%) |
| Mar 2012 | - | $13.24 B(-2.7%) |
| Dec 2011 | $13.61 B(-14.6%) | $13.61 B(-1.1%) |
| Sept 2011 | - | $13.77 B(-12.6%) |
| June 2011 | - | $15.75 B(-1.4%) |
| Mar 2011 | - | $15.97 B(+0.3%) |
| Dec 2010 | $15.93 B | $15.93 B(-7.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $17.23 B(+7.1%) |
| June 2010 | - | $16.08 B(-0.7%) |
| Mar 2010 | - | $16.19 B(-1.6%) |
| Dec 2009 | $16.46 B(-5.8%) | $16.46 B(-4.5%) |
| Sept 2009 | - | $17.23 B(+0.7%) |
| June 2009 | - | $17.11 B(+1.1%) |
| Mar 2009 | - | $16.94 B(-3.1%) |
| Dec 2008 | $17.48 B(-2.1%) | $17.48 B(-0.2%) |
| Sept 2008 | - | $17.52 B(-3.3%) |
| June 2008 | - | $18.12 B(+1.2%) |
| Mar 2008 | - | $17.91 B(+0.3%) |
| Dec 2007 | $17.86 B(+252.2%) | $17.86 B(+13.9%) |
| Sept 2007 | - | $15.68 B(+103.6%) |
| June 2007 | - | $7.70 B(+48.2%) |
| Mar 2007 | - | $5.19 B(+2.5%) |
| Dec 2006 | $5.07 B(+17.6%) | $5.07 B(-3.5%) |
| Sept 2006 | - | $5.25 B(+4.1%) |
| June 2006 | - | $5.04 B(-0.5%) |
| Mar 2006 | - | $5.07 B(+17.6%) |
| Dec 2005 | $4.31 B(-5.6%) | $4.31 B(-2.4%) |
| Sept 2005 | - | $4.42 B(-2.2%) |
| June 2005 | - | $4.52 B(+4.8%) |
| Mar 2005 | - | $4.31 B(-5.6%) |
| Dec 2004 | $4.57 B(+74.3%) | $4.57 B(+63.6%) |
| Sept 2004 | - | $2.79 B(-39.1%) |
| June 2004 | - | $4.58 B(+26.5%) |
| Mar 2004 | - | $3.62 B(+38.2%) |
| Dec 2003 | $2.62 B(+22.8%) | $2.62 B(+9.5%) |
| Sept 2003 | - | $2.39 B(+4.4%) |
| June 2003 | - | $2.29 B(+4.3%) |
| Mar 2003 | - | $2.20 B(+3.0%) |
| Dec 2002 | $2.13 B(-10.6%) | $2.13 B(+2.5%) |
| Sept 2002 | - | $2.08 B(+1.6%) |
| June 2002 | - | $2.05 B(-9.5%) |
| Mar 2002 | - | $2.26 B(-5.1%) |
| Dec 2001 | $2.39 B(+19.5%) | $2.39 B(-11.9%) |
| Sept 2001 | - | $2.71 B(+4.0%) |
| June 2001 | - | $2.61 B(+1.3%) |
| Mar 2001 | - | $2.57 B(+28.8%) |
| Dec 2000 | $2.00 B(-18.7%) | $2.00 B(-16.1%) |
| Sept 2000 | - | $2.38 B(-3.9%) |
| June 2000 | - | $2.48 B(+24.4%) |
| Mar 2000 | - | $1.99 B(-18.8%) |
| Dec 1999 | $2.46 B(+33.0%) | $2.46 B(+3.3%) |
| Sept 1999 | - | $2.38 B(-4.3%) |
| June 1999 | - | $2.48 B(+34.5%) |
| Dec 1998 | $1.85 B(+16.9%) | $1.85 B(+17.1%) |
| June 1998 | - | $1.58 B(-0.2%) |
| Dec 1997 | $1.58 B(-7.1%) | $1.58 B(-7.1%) |
| Dec 1996 | $1.70 B(-0.4%) | $1.70 B(-0.4%) |
| Dec 1995 | $1.71 B(+4.7%) | $1.71 B(+4.4%) |
| June 1995 | - | $1.63 B(+0.3%) |
| Dec 1994 | $1.63 B(+1.2%) | $1.63 B(+1.2%) |
| Dec 1993 | $1.61 B(-21.5%) | $1.61 B |
| Dec 1992 | $2.05 B(-44.8%) | - |
| Dec 1991 | $3.71 B(-2.3%) | - |
| Dec 1990 | $3.80 B | - |
FAQ
- What is AstraZeneca annual total long term liabilities?
- What is the all time high annual total long term liabilities for AstraZeneca?
- What is AstraZeneca annual total long term liabilities year-on-year change?
- What is AstraZeneca quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for AstraZeneca?
- What is AstraZeneca quarterly long term liabilities year-on-year change?
What is AstraZeneca annual total long term liabilities?
The current annual total long term liabilities of AZN is $31.41 B
What is the all time high annual total long term liabilities for AstraZeneca?
AstraZeneca all-time high annual total long term liabilities is $43.48 B
What is AstraZeneca annual total long term liabilities year-on-year change?
Over the past year, AZN annual total long term liabilities has changed by -$1.72 B (-5.19%)
What is AstraZeneca quarterly total long term liabilities?
The current quarterly long term liabilities of AZN is $38.19 B
What is the all time high quarterly long term liabilities for AstraZeneca?
AstraZeneca all-time high quarterly total long term liabilities is $43.66 B
What is AstraZeneca quarterly long term liabilities year-on-year change?
Over the past year, AZN quarterly total long term liabilities has changed by +$7.91 B (+26.14%)